^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

nonavalent HPV vaccine

i
Other names: nonavalent HPV vaccine, Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli)
Associations
Trials
Company:
Wantai BioPharm
Drug class:
Immunostimulant
Related drugs:
Associations
Trials
17d
Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women (clinicaltrials.gov)
P=N/A, N=392, Active, not recruiting, Xiamen University | Not yet recruiting --> Active, not recruiting | Trial completion date: Dec 2024 --> Mar 2025 | Trial primary completion date: Mar 2024 --> Mar 2025
Enrollment closed • Trial completion date • Trial primary completion date
|
Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) • nonavalent HPV vaccine
11ms
Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women (clinicaltrials.gov)
P=N/A, N=392, Not yet recruiting, Xiamen Ophthalmology Center Affiliated to Xiamen University
New trial
|
Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) • nonavalent HPV vaccine
11ms
An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old (clinicaltrials.gov)
P3, N=1382, Active, not recruiting, Xiamen Ophthalmology Center Affiliated to Xiamen University | Trial completion date: Dec 2023 --> Dec 2025 | Trial primary completion date: Dec 2023 --> Dec 2025
Trial completion date • Trial primary completion date • Head-to-Head
|
nonavalent HPV vaccine
over1year
Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age (clinicaltrials.gov)
P3, N=488, Completed, Xiamen University | Active, not recruiting --> Completed | Trial completion date: Dec 2022 --> Jul 2022
Trial completion • Trial completion date
|
Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) • nonavalent HPV vaccine